Dynavax Technologies Corp. (NASDAQ: DVAX) is -15.52% lower on its value in year-to-date trading and has touched a low of $9.74 and a high of $15.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DVAX stock was last observed hovering at around $11.39 in the last trading session, with the day’s gains setting it 0.42%.
Currently trading at $11.81, the stock is 8.40% and 7.02% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.82 million and changing 3.69% at the moment leaves the stock 1.13% off its SMA200. DVAX registered -17.01% loss for a year compared to 6-month loss of 3.87%. The firm has a 50-day simple moving average (SMA 50) of $11.035 and a 200-day simple moving average (SMA200) of $11.6781.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 6.01% gain in the last 1 month and extending the period to 3 months gives it a 5.54%, and is 7.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.62% over the week and 3.02% over the month.
Dynavax Technologies Corp. (DVAX) has around 408 employees, a market worth around $1.55B and $249.69M in sales. Current P/E ratio is 108.05 and Fwd P/E is 32.23. Profit margin for the company is 6.88%. Distance from 52-week low is 21.25% and -22.05% from its 52-week high. The company has generated returns on investments over the last 12 months (1.92%).
with sales reaching $84.17M over the same period.The EPS is expected to grow by 485.88% this year, but quarterly earnings will post 21.10% year-over-year.
Dynavax Technologies Corp. (DVAX) Top Institutional Holders
328.0 institutions hold shares in Dynavax Technologies Corp. (DVAX), with institutional investors hold 108.18% of the company’s shares. The shares outstanding are 131.04M, and float is at 130.41M with Short Float at 13.08%. Institutions hold 107.82% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 21.9 million shares valued at $245.97 million. The investor’s holdings represent 16.7308% of the DVAX Shares outstanding. As of 2024-06-30, the second largest holder is DEEP TRACK CAPITAL, LP with 10.9 million shares valued at $122.41 million to account for 8.3259 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 9.37 million shares representing 7.1594% and valued at over $105.26 million, while STATE STREET CORP holds 6.0824 of the shares totaling 7.96 million with a market value of $89.42 million.
Dynavax Technologies Corp. (DVAX) Insider Activity
The most recent transaction is an insider sale by CANO FRANCIS, the company’s Director. SEC filings show that CANO FRANCIS sold 3,615 shares of the company’s common stock on May 31 ’24 at a price of $11.93 per share for a total of $43127.0. Following the sale, the insider now owns 36905.0 shares.
Dynavax Technologies Corp. disclosed in a document filed with the SEC on Mar 01 ’24 that Burgess Justin (Chief Accounting Officer) sold a total of 20,526 shares of the company’s common stock. The trade occurred on Mar 01 ’24 and was made at $12.78 per share for $0.26 million. Following the transaction, the insider now directly holds 0.0 shares of the DVAX stock.
Still, SEC filings show that on Jan 04 ’24, Janssen Robert (SVP and CMO) disposed off 1,500 shares at an average price of $15.00 for $22500.0. The insider now directly holds 49,925 shares of Dynavax Technologies Corp. (DVAX).
